Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PMDA to Start 2nd 5-Year Plan a Year Ahead of Schedule
January 22, 2007
- JGPMA Proposes New Drug Benefit System
January 22, 2007
- Reform of Review System a Top Priority for PFSB: Mr Takahashi
January 22, 2007
- MEDICAL DEVICE NEWS IN BRIEF
January 22, 2007
- REGULATORY NEWS IN BRIEF ―２―
January 15, 2007
- FY2007 Draft Budget Includes \68.8 Bil. to Promote Life Science R&D: MEXT
January 15, 2007
- Next Clinical Trial Promotion Plan to Be Announced By End of March
January 15, 2007
- UK DOH's Expert Group Issues Recommendations on First-in-man Trials of High-risk Agents
January 15, 2007
- R&D NEWS IN BRIEF
January 15, 2007
- 10 Questions for the New Year
January 15, 2007
- Asymptomatic Hepatitis B 57% : Bristol-Myers
January 15, 2007
- Seminar
January 15, 2007
- Korosho to Initiate "Purity Testing" Project for Generics
January 15, 2007
- Blopress Remains Top Selling Drug for 3rd Year in a Row
January 15, 2007
- GENERIC NEWS IN BRIEF
January 15, 2007
- BUSINESS NEWS IN BRIEF
January 15, 2007
- OPINION
January 15, 2007
- Burgeoning Market for ARBs -Hot Battlefield for Megapharmas-
January 15, 2007
- Constipation Does Not Increase Risk of Colorectal Cancer: Korosho Study Group
January 15, 2007
- Korosho Committed to Promoting Innovation in Pharma Industry: Health Minister
January 15, 2007
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…